Santen Pharmaceutical News

Santen Pharmaceutical: March 2025 quarterly earnings report [IFRS] (consolidated)

Aug 6 02:00 ET

Santen Pharmaceutical: Interim report

Jun 25 20:45 ET

Santen Pharmaceutical: Extraordinary Report

Jun 25 02:57 ET

Santen Pharmaceutical: Confirmation letter

Jun 25 02:46 ET

Santen Pharmaceutical: Securities Report - 112th Period (April 1, 2023 to March 31, 2024)

Jun 25 02:45 ET

Santen Pharmaceutical: Summary of financial results for the fiscal year ending 2024/3 [IFRS] (consolidated)

May 9 02:00 ET

Santen Pharmaceutical: Extraordinary Report

Mar 25 03:39 ET

Santen Pharmaceutical: Confirmation

Feb 13 01:05 ET

Santen Pharmaceutical: Quarterly Report - 112th Quarter (2023/10/01 - 2023/12/31)

Feb 13 01:04 ET

Santen Pharmaceutical: Notice regarding revisions to dividend forecasts

Feb 8 01:00 ET

Santen Pharmaceutical: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2024 [IFRS] (consolidated)

Feb 8 01:00 ET

Santen Pharmaceutical: Confirmation letter

Nov 9, 2023 01:07 ET

Santen Pharmaceutical: Quarterly Report - Period 112th Second Quarter (2023/07/01 - 2023/09/30)

Nov 9, 2023 01:03 ET

Santen Pharmaceutical: Summary of Financial Results for the 2nd Quarter Ending March 2024 [IFRS] (consolidated)

Nov 7, 2023 01:00 ET

Santen Pharmaceutical: Notice regarding revisions to full-year earnings forecasts

Sep 19, 2023 21:00 ET

Santen Pharmaceutical: Confirmation letter

Aug 7, 2023 03:07 ET

Santen Pharmaceutical: Quarterly Report - 112th Quarter (2023/04/01 - 2023/06/30)

Aug 7, 2023 03:03 ET

Santen Pharmaceutical: Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024 [IFRS] (Consolidated)

Aug 3, 2023 02:00 ET

Santen Pharmaceutical: Extraordinary Report

Jun 27, 2023 22:37 ET

Santen Pharmaceutical: Confirmation letter

Jun 27, 2023 02:33 ET